Symptoms
Common signs and symptoms of Hereditary Hemorrhagic Telangiectasia include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Hereditary Hemorrhagic Telangiectasia.
Hereditary Hemorrhagic Telangiectasia results from mutations in specific genes that control blood vessel development.
Hereditary Hemorrhagic Telangiectasia results from mutations in specific genes that control blood vessel development. The most common culprits are the ENG gene (causing HHT type 1) and the ACVRL1 gene (causing HHT type 2), though mutations in several other genes can also trigger the condition. These genes normally produce proteins that help regulate how blood vessels form and maintain their proper structure during development and throughout life.
When these genes malfunction, blood vessels develop abnormally, creating direct connections between arteries and veins.
When these genes malfunction, blood vessels develop abnormally, creating direct connections between arteries and veins. Think of it like a highway system where major roads connect directly without the smaller side streets that normally handle local traffic. In healthy blood vessels, tiny capillaries act like those side streets, allowing controlled exchange of oxygen and nutrients. Without this capillary network, blood flows directly from high-pressure arteries into low-pressure veins, creating fragile, enlarged vessels prone to bleeding.
The condition follows an autosomal dominant inheritance pattern, meaning only one faulty gene copy from either parent causes HHT in their child.
The condition follows an autosomal dominant inheritance pattern, meaning only one faulty gene copy from either parent causes HHT in their child. Each pregnancy carries a 50% risk of passing the condition to the next generation. However, the severity and specific symptoms can vary dramatically even within the same family, as other genetic and environmental factors influence how the condition manifests in each person.
Risk Factors
- Having a parent with HHT or related symptoms
- Family history of frequent nosebleeds
- Genetic mutations in ENG, ACVRL1, or SMAD4 genes
- Previous generations with unexplained strokes
- Family members with lung or brain blood vessel problems
- Relatives with characteristic skin lesions
- European ancestry (slightly higher prevalence)
- Family history of liver enlargement
- Blood relatives with gastrointestinal bleeding
Diagnosis
How healthcare professionals diagnose Hereditary Hemorrhagic Telangiectasia:
- 1
Diagnosing HHT often begins when doctors notice a pattern of symptoms that seem unrelated at first glance.
Diagnosing HHT often begins when doctors notice a pattern of symptoms that seem unrelated at first glance. The Curacao criteria provide a standardized approach, looking for four key features: recurrent nosebleeds, characteristic small blood vessel lesions (telangiectasias), internal blood vessel malformations, and a family history of HHT. Having three or four of these criteria indicates a definitive diagnosis, while two criteria suggest possible HHT requiring further investigation.
- 2
Genetic testing can confirm the diagnosis and identify the specific gene mutation responsible.
Genetic testing can confirm the diagnosis and identify the specific gene mutation responsible. Blood tests look for mutations in the ENG, ACVRL1, SMAD4, and other associated genes. This information helps predict which organs might be affected and guides family screening recommendations. However, genetic testing doesn't detect all cases, as some people have mutations in genes not yet identified or have mosaic patterns that are harder to detect.
- 3
Comprehensive screening examines potentially affected organs even when symptoms aren't apparent.
Comprehensive screening examines potentially affected organs even when symptoms aren't apparent. This typically includes: - Contrast echocardiography to detect lung blood vessel malformations - Brain and spinal MRI to identify central nervous system lesions - CT scans of the chest and abdomen - Liver function tests and imaging - Complete blood counts to check for anemia Regular screening helps catch developing problems before they cause serious complications, making early detection and ongoing monitoring essential parts of HHT care.
Complications
- The most serious complications of HHT involve internal blood vessel malformations that can cause sudden, life-threatening events.
- Brain and spinal cord lesions carry risks of stroke, seizures, or neurological deficits, particularly in younger adults who might otherwise never expect such problems.
- Pulmonary arteriovenous malformations can lead to strokes through paradoxical embolism, where blood clots bypass lung filtration, or brain abscesses from bacteria that would normally be filtered out by healthy lungs.
- Chronic complications develop gradually but significantly impact quality of life.
- Severe anemia from ongoing blood loss causes fatigue, weakness, and reduced exercise tolerance.
- Liver involvement can progress to cirrhosis, portal hypertension, or heart failure from increased blood flow demands.
- High-output heart failure may develop when large arteriovenous malformations force the heart to work harder to maintain adequate circulation.
- Gastrointestinal bleeding, while often manageable, can become severe enough to require emergency intervention or frequent blood transfusions.
Prevention
- Avoiding nose picking, aggressive nose blowing, and nasal trauma
- Using humidifiers and saline sprays to keep nasal passages moist
- Avoiding blood-thinning medications unless absolutely necessary
- Getting prompt treatment for respiratory infections
- Avoiding activities with high stroke risk if brain lesions are present
- Maintaining good iron levels through diet and supplements
Treatment for HHT focuses on managing symptoms and preventing complications rather than curing the underlying genetic condition.
Treatment for HHT focuses on managing symptoms and preventing complications rather than curing the underlying genetic condition. Nosebleed management often starts with simple measures like saline rinses, humidifiers, and gentle nose care techniques. When conservative approaches fail, treatments range from topical medications like estrogen gels to procedures such as laser therapy, electrocautery, or nasal closure in severe cases. Some people benefit from antifibrinolytic medications that help blood clot more effectively.
Internal blood vessel malformations require specialized intervention based on their location and risk level.
Internal blood vessel malformations require specialized intervention based on their location and risk level. Pulmonary arteriovenous malformations larger than 3mm typically need treatment through embolization, where radiologists insert coils or plugs to close abnormal connections. Brain and spinal cord lesions may require surgical removal or stereotactic radiosurgery, depending on their size, location, and bleeding risk. These procedures carry their own risks, so doctors carefully weigh benefits against potential complications.
Anemia from chronic bleeding often needs ongoing management through iron supplementation, dietary changes, or in severe cases, blood transfusions.
Anemia from chronic bleeding often needs ongoing management through iron supplementation, dietary changes, or in severe cases, blood transfusions. Some patients benefit from medications that reduce bleeding, such as tranexamic acid or hormonal therapies. Liver involvement may require monitoring and occasionally liver transplantation in severe cases with complications like heart failure.
Emerging treatments show promise for the future.
Emerging treatments show promise for the future. Anti-angiogenic drugs like bevacizumab help some people by reducing blood vessel growth and bleeding. Research into gene therapy and other molecular approaches continues, though these remain experimental. The key to successful treatment lies in working with healthcare teams experienced in HHT, as the condition's complexity requires coordinated care across multiple specialties.
Living With Hereditary Hemorrhagic Telangiectasia
Living successfully with HHT requires balancing vigilance with normalcy. Many people adapt well once they understand their condition and establish good healthcare relationships. Regular follow-up with HHT specialists helps monitor for new developments and adjust treatment plans. Keeping emergency information readily available, including details about internal lesions and bleeding risks, helps healthcare providers make informed decisions during urgent situations.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Apr 26, 2026v1.0.0
- Published by DiseaseDirectory